Basilea Capital Markets Day

11 April 2024
Park Hyatt, Zurich

We were pleased to have you at our Capital Markets Day!

You can find the presentation here.

Event-Videos

Welcome

David Veitch
Chief Executive Officer at Basilea

Financial position & business model

Adesh Kaul
Chief Financial Officer at Basilea

New assets in drug pipeline

Marc Engelhardt
M.D., Ph.D.
Chief Medical Officer at Basilea

Treating infectious diseases

Oliver A. Cornely
M.D., Ph.D.
Professor of Translational Research, Faculty of Medicine, University of Cologne


Thomas L. Holland
M.D., Ph. D.
Associate Professor of Medicine, Infectious Diseases, Department of Medicine, Duke University

Round table and Q&A

Key take aways and wrap up

David Veitch
Chief Executive Officer at Basilea

Full Event

Program

We were delighted to have Professor Oliver A. Cornely and Professor Thomas L. Holland as our guest speakers.

April 11
13:00
Check-in start


14:00
Welcome

David Veitch, CEO

14:15
Financial position & business model

Adesh Kaul, CFO

incl. Q&A

14:30
The new assets in our drug pipeline: Fosmanogepix, BAL2062 and tonabacase

Marc Engelhardt, M.D., Ph.D., CMO

15:00
Coffee-Break
15:30
Treating infectious diseases: progress, current limitations and future needs

Invasive fungal infections
Professor Oliver A. Cornely, Professor of Translational Research, Faculty of Medicine, University of Cologne

Staphylococcus aureus bacteremia
Professor Thomas L. Holland, Associate Professor of Medicine, Infectious Diseases, Department of Medicine, Duke University

16:30
Round table and Q&A
16:50
Key Take Aways & Wrap Up

David Veitch, CEO

17:00
Networking & Apéro
18:00
End

Interested in a meeting?

If you have further questions or would like to request a meeting with the Management or IR team, please do not hesitate to reach out to Ms. Dung Tran, Investor Relations Coordinator, at NgocDung.Tran@basilea.com .

Event-Highlights

Speakers

Oliver A. Cornely
M.D., Ph.D.

Professor of Translational Research, Faculty of Medicine, University of Cologne

More info

Thomas L. Holland
M.D., Ph.D.

Associate Professor of Medicine, Infectious Diseases, Department of Medicine, Duke University

More info

David Veitch

Chief Executive Officer at Basilea

More info

Adesh Kaul

Chief Financial Officer at Basilea

More info

Marc Engelhardt
M.D., Ph.D.

Chief Medical Officer at Basilea

More info

“Basilea is living in exciting times.
We’re on the verge of something big, in the changing world of anti-infectives."

David Veitch | CEO Basilea Pharmaceutica